Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202572) titled 'A Study Of Virtual Reality Vs Sham VR On Fibromyalgia' on Sept. 30.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Mayo Clinic
Condition:
Virtual Reality
Sham VR
Fibromyalgia
Intervention:
Device: TRIPP VR Meditation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 29, 2025
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07202572
Published by HT Digital Content...